SG11201806182RA - Methods of producing viruses - Google Patents

Methods of producing viruses

Info

Publication number
SG11201806182RA
SG11201806182RA SG11201806182RA SG11201806182RA SG11201806182RA SG 11201806182R A SG11201806182R A SG 11201806182RA SG 11201806182R A SG11201806182R A SG 11201806182RA SG 11201806182R A SG11201806182R A SG 11201806182RA SG 11201806182R A SG11201806182R A SG 11201806182RA
Authority
SG
Singapore
Prior art keywords
virus
international
methods
viruses
pct
Prior art date
Application number
SG11201806182RA
Other languages
English (en)
Inventor
Lindsey Ann Toon
Ralf Hoffmann
Original Assignee
Benchmark Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1601861.6A external-priority patent/GB201601861D0/en
Application filed by Benchmark Animal Health Ltd filed Critical Benchmark Animal Health Ltd
Publication of SG11201806182RA publication Critical patent/SG11201806182RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10061Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/30011Nodaviridae
    • C12N2770/30034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/30011Nodaviridae
    • C12N2770/30051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2796/00Viruses not covered by groups C12N2710/00 - C12N2795/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201806182RA 2016-02-02 2017-02-02 Methods of producing viruses SG11201806182RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1601861.6A GB201601861D0 (en) 2016-02-02 2016-02-02 Methods of producing viruses
GB201618549 2016-11-03
PCT/GB2017/050259 WO2017134441A1 (en) 2016-02-02 2017-02-02 Methods of producing viruses

Publications (1)

Publication Number Publication Date
SG11201806182RA true SG11201806182RA (en) 2018-08-30

Family

ID=58018136

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806182RA SG11201806182RA (en) 2016-02-02 2017-02-02 Methods of producing viruses

Country Status (11)

Country Link
US (1) US10450544B2 (enExample)
EP (1) EP3411064B1 (enExample)
JP (1) JP2019511208A (enExample)
CN (1) CN109414494A (enExample)
AU (1) AU2017215287A1 (enExample)
BR (1) BR112018015527A2 (enExample)
CA (1) CA3011920A1 (enExample)
CL (1) CL2018002042A1 (enExample)
ES (1) ES2795040T3 (enExample)
SG (1) SG11201806182RA (enExample)
WO (1) WO2017134441A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111118171A (zh) * 2019-12-31 2020-05-08 广东省测试分析研究所(中国广州分析测试中心) 一种鉴别鱼翅种的dna条形码引物对、试剂盒及方法
CN113122510A (zh) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
TWI347364B (en) * 2003-02-19 2011-08-21 Novartis Ag Inactivated nodavirus vaccine
NO332608B1 (no) * 2011-03-16 2012-11-19 Norwegian School Of Veterinary Science Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk
CN104531608A (zh) * 2015-01-12 2015-04-22 福建省农业科学院生物技术研究所 一种欧洲鳗鲡肝脏细胞系及其构建方法和应用
CN105192298A (zh) * 2015-11-11 2015-12-30 浙江锦天生物科技有限公司 一种日本鳗鲡用复合微生态饲料添加剂

Also Published As

Publication number Publication date
CN109414494A (zh) 2019-03-01
EP3411064A1 (en) 2018-12-12
ES2795040T3 (es) 2020-11-20
CA3011920A1 (en) 2017-08-10
BR112018015527A2 (pt) 2018-12-26
US10450544B2 (en) 2019-10-22
US20190040354A1 (en) 2019-02-07
WO2017134441A1 (en) 2017-08-10
EP3411064B1 (en) 2020-02-26
CL2018002042A1 (es) 2019-03-22
JP2019511208A (ja) 2019-04-25
AU2017215287A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
SG11201907870VA (en) Compositions and methods for inhibition of lineage specific proteins
SG11201805835WA (en) Modified oncolytic virus
SG11201805993UA (en) Genetically modified non-human mammals by multi-cycle electroporation of cas9 protein
SG11201807279QA (en) Binding proteins and methods of use thereof
SG11201806988UA (en) Improved differentiation method
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201901996UA (en) Formulations of ( r)-2-amino-3-phenylpropyl carbamate
SG11201806002SA (en) Methods for extending the replicative capacity of somatic cells during an ex vivo cultivation process
SG11201804144UA (en) High-throughput imaging-based methods for predicting cell-type-specific toxicity of xenobiotics with diverse chemical structures
SG11201907298WA (en) Methods and compositions for gene transfer across the vasculature
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201809857TA (en) Anti-CTLA-4 Antibodies
SG11201806340YA (en) Zika virus vaccine
SG11201803703UA (en) Anti-complement factor c1q fab fragments and uses thereof
SG11201908240YA (en) Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device
SG11201909561RA (en) Octree-based convolutional neural network
SG11201900058YA (en) Method of generating mesenchymal stem cells and uses thereof
SG11201903012RA (en) Anti-c1s antibodies and methods of use thereof
SG11201906322UA (en) Application of dry hydrogen peroxide (dhp) gas to methods of poultry production
SG11201900057WA (en) Biomatrix scaffolds for use in diagnosing and modeling cancer
SG11201903353WA (en) Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
SG11201907208XA (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SG11201809594WA (en) Nicotine particles and compositions
SG11201806587RA (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same